Cancer

Many environmental factors can influence cancer incidence. Genes also play a role. However, the causes of many types of cancer are still unknown.

Les på norsk

From NCD report

Indicators for Non-Communicable Diseases (NCD)

Updated 02.12.2019

Cancer incidence (Indicator 2)

The indicator describes the following: cancer incidence, by type of cancer, per 100 000 person years.

Indicators for Non-Communicable Diseases (NCD)

Updated 07.01.2020

Palliative cancer care (Indicator 20)

The indicator describes the following: Access to palliative care assessed by morphine-equivalent consumption of strong opioid analgesics (in grams of morphine) per death from cancer.

Reports

Systematic review

Published 06.02.2020

Treatment options for metastatic prostate cancer

We aimed to summarise findings about the effectiveness of androgen suppression therapy, chemotherapy, radiation and radioactive treatment in addition to standard care for metastatic prostate cancer.

Mapping review

Published 29.08.2019

Effectiveness of treatment for localized prostate cancer

The Centre for shared decision making commissioned the Norwegian Institute of Public Health to summarize findings about the effectiveness of relevant treatment for localized prostate cancer.

Health technology assessment

Published 16.08.2019

Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer

We have considered a molecular profiling panel, Prosigna, which is meant to improve the assessment of recurrence risk among women who have undergone surgical treatment for breast cancer.

Mapping review

Published 23.05.2018

Effectiveness of mastectomy for women with breast cancer: evidence base for a shared decision making tool

We were commissioned to identify and summarize key findings from systematic reviews about the effects of mastectomy for women with small breast cancer tumour.

Health technology assessment

Published 09.04.2018

177Lutetium-based peptide receptor radionuclide therapy for treating neuroendocrine tumours: a health technology assessment

The Commission Forum representing the four National Regional Health Authorities (RHA) in Norway asked the Norwegian Institute of Public Health to conduct a full HTA of 177Lu-PRRT.

Health technology assessment

Published 23.03.2018

Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment

This is a HTA of the diagnostic accuracy, clinical effectiveness and budget impact of breast cancer screening using MRI in combination with mammography, for women with BRCA1/2 genetic mutations.

Health technology assessment

Published 04.09.2017

Digital Breast Tomosynthesis with Hologic 3D mammography Selenia Dimensions System for use in breast cancer screening

We were to perform a single technology assessment (STA) regarding “Three dimensional digital breast tomosynthesis in screening for breast cancer”.

Systematic review

Published 16.12.2016

The effectiveness of physical exercise for people with cancer

We have summarised the results from five systematic reviews, on the effects of exercise for cancer patients during and after cancer treatment, including a total of 119 randomised clinical trials.

Health technology assessment

Published 15.12.2016

Health technology assessment of four drugs for patients with metastatic castration resistant prostate cancer

In this HTA we have compared the relative effectiveness and cost-effectiveness of four drugs used for patients with metastatic castration resistant prostate cancer.

Research findings

Nordic twin study highlights familial cancer risk
As many large breast tumours detected without mammography
Already reached target of 25 per cent fewer premature deaths

Projects

Childhood cancer and prenatal environmental exposures
18.03.20